JPMorgan's new financing gives the crypto and AI-datacenter company a $100 million revolver alongside a far larger $500 million letter-of-credit line, whose purpose remains unstated.
Core Scientific has entered a new credit facility with JPMorgan combining a $100 million revolving line with a $500 million letter-of-credit facility, secured by substantially all of the company's assets. The facility carries a rate of SOFR plus 1.75%, matures in August 2029 with a one-year extension option, and was undrawn at close. It includes covenants requiring Core Scientific to maintain minimum liquidity of $150 million and a minimum market capitalization of $3.0 billion.
The company disclosed the agreement Thursday in an 8-K covering Items 1.01, 2.03, 7.01 and 9.01. The credit agreement itself is dated August 25.
Core Scientific shares traded between $17.63 and $18.52 Thursday, closing at $17.82, up 2.30% from the prior close of $17.42. That is a muted reaction relative to the size of the facility, and it moved roughly in line with a broadly positive day for technology stocks generally. There is little basis in the available evidence for tying the stock's modest gain specifically to the financing disclosure.
What stands out in the facility itself is its composition. A $500 million letter-of-credit line dwarfs the $100 million revolver it sits alongside, and neither the 8-K nor any available coverage explains what that letter-of-credit capacity is meant to back. Letter-of-credit facilities are typically used to guarantee performance on specific obligations, not to fund general operations the way a revolver does. That makes the size of this one, five times the revolver itself, a detail that calls for more explanation than the filing provides.
Core Scientific operates as a crypto and AI-datacenter infrastructure company, a business where power-purchase agreements and hosting contracts can carry substantial collateral or performance-guarantee requirements. That makes power or hosting-related collateral a plausible use for a facility this size. It is not a confirmed one. Neither the company nor the filing has said what the $500 million is actually for, and the letter-of-credit component of this financing remains a larger open question than the facility's modest stock reaction would suggest.